Generic placeholder image

Current Medicinal Chemistry


ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Anticancer Metallotherapeutics in Preclinical Development

Author(s): G. N. Kaluderovic and R. Paschke

Volume 18, Issue 31, 2011

Page: [4738 - 4752] Pages: 15

DOI: 10.2174/092986711797535308

Price: $65


This article reviews recent studies of platinum and other metal-containing antitumor drugs in preclinical development. A short overview of the development of cisplatin-based drug generations is given. Some pioneering strategies towards unconventional drugs, such as platinum complexes with biomolecules and carrier ligands, organoplatinum and multinuclear platinum complexes developed in recent years are outlined. Furthermore, nonplatinum-based antitumor drugs containing ruthenium(II/III), gallium(III), titanium(IV) or tin(IV) that illustrate the prominent strategies are presented with an emphasis on recent developments. In addition, alternatives for water insoluble drugs will be discussed. A brief overview of development of nanodrug delivery systems and their potential as alternative cancerostatic carriers are discussed.

Keywords: Anticancer metallotherapeutics, cisplatin, drug delivery system, gallium(III), liposomes, platinum(II), platinum(IV), nanomaterials, organoplatinum(IV), ruthenium(II), ruthenium(III), tin(IV), titanium(IV), transplatinum complexes

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy